Special Issue "New Opportunities and Challenges of Early Psychosis"
Deadline for manuscript submissions: 31 May 2021.
2. Assistant Professor, Department of Legal Medicine, Psychiatry and Patology (Psychiatry Area), School of Medicine, Universidad Complutense, Madrid, Spain.
Interests: Psychotic Disorders; Prodrome; Neurocognition; Risk factors; Diagnosis; Biomarkers; Neuroimaging; Early life adversity; Cognitive-enhancers; Early Intervention
Over the past two decades, the early psychosis field has advanced and expanded substantially. A great deal of progress has been made understanding phenomenology, neurobiology and outcome during early phase of psychotic disorders. Although there is extensive investigation of early signs of risk and evidence-based treatments, psychotic disorders continue to severely affect both young and adults. Schizophrenia and other psychotic disorders represent the third leading cause of disability-adjusted life years worldwide. Early diagnosis and treatment of first-episode psychosis is crucial for short and long-term prognosis. Delayed identification of symptoms and a longer duration of untreated psychosis may lead to challenges in functional and clinical outcomes. Effective and timely interventions have shown to improve psychopathology, quality of life and vocational development of individuals with psychosis. With major unmet needs such as cognitive and negative symptoms, early psychosis research still faces several conceptual, methodological and treatment challenges. In this Special Issue, we will focus on recent advances in understanding and treating the early phase of psychotic disorders, as well as some of the challenges to furthering the application of a broader preventive model.
Qualitative and quantitative original research or reviews of current knowledge in the early psychosis field are welcomed.
Prof. Dr. Marta Rapado-Castro
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- First-Episode Psychosis
- Risk Factors
- Early Detection
- Early Intervention
- Clinical Outcomes
- Functional outcomes
- Novel treatments